PBSS Symposium: Preclinical Models to Guide Therapeutic Development in Oncology

Foster City, CA


8:45am - 5:00pm

List of Speakers and Presentations (order of presentations TBD):

Symposium Overview and Relevance to Contemporary Issues in Development of Therapeutic Agents for Oncology (Mark Merchant, Genentech)
Preclinical Mouse Models for Oncology and Immuno-oncology Applications (Maryland Franklin, Covance-Preclinical Oncology)
Preclinical development of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of advanced solid tumors (Karen Rex, Amgen)
Case Study: Bench to Bedside with Immune Stimulating Antibody Conjugates (ISAC) (Michael Alonso, Bolt Biotherapeutics)
Preclinical investigation of NKTR-255, a polymer conjugated IL-15 with potent NK cell activation and anti-tumor activity in combination with tumor targeting antibodies (Saul Kivimae, Nektar)
Advancing CAR T Cell Therapy for the Treatment of Solid Tumors (Saul Priceman, City of Hope)
The Utility of Preclinical Models in Development of CAR T (John Langowski, Kite Pharma)
Current Status in the Application of Organoids to Oncology Drug Discovery and Biomarker Identification (Yorick Post, Hubrecht Institute – Hans Clevers Group; currently Surrozen; Philippe Depeille, UCSF)

Click Here for More Information

Contact: Monika Wientzek
Contact Email:

Event Address:

Crowne Plaza, 1221 Chess Drive, Foster City, CA